Jaguar Health joint venture reports preclinical study shows coca leaf extract prevents weight gain in mice

Jaguar Animal Health, Inc.

JAGX

0.00

Jaguar Health disclosed positive preclinical results for a coca leaf extract being developed for post-GLP-1 weight maintenance.
Results have already been presented in the announcement, based on a 20-day mouse study run at the University of Calgary.
The extract prevented weight gain on a high-fat diet without curbing food intake or boosting activity, supporting its potential as a maintenance therapy.
The candidate is positioned for prescription-drug development under FDA botanical drug guidance, targeting weight regain following GLP-1 discontinuation.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jaguar Health Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202606180900ACCESSWRNAPR_____1178383) on June 18, 2026, and is solely responsible for the information contained therein.

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.